Users Discontinuing Weight-Loss Jabs Put On Pounds at a Quadrupled Rate Compared to Dieters

Fresh analysis reveals that individuals who come off popular weight-loss injections like semaglutide or tirzepatide tend to recover lost weight far faster than those who end conventional lifestyle plans.

Research printed in a major health publication demonstrates that while obese people can lose substantial amounts of their total mass while using the jabs, the weight comes back at an average rate of nearly a kilo each month upon discontinuation.

"Individuals using such drugs must be aware of the risk of fast rebound weight gain when the treatment concludes," stated researcher Dr. Susan Jebb.

Such speed of regain suggests a reversion to pre-treatment mass in about a year and a half.

Comparing Therapies

The analysis, which reviewed dozens of trials involving thousands of participants, contrasted the effects of the injectable medications with other pills.

Researchers emphasize that individuals who lose weight through lifestyle changes alone typically have a slower creep back—around 0.1 kg a month—post-intervention.

Explaining the Quick Rebound

Experts suggest the way of the jabs accounts for the accelerated regain.

These medications copy a body's own chemical called glucagon-like peptide-1, which moderates appetite.

"Artificially providing GLP-1 levels far above than normal could lead to the system to generate a reduced amount of its endogenous GLP-1, and may also lessen responsiveness to its actions," noted Dr. Adam Collins, a nutrition specialist.

"Stopping of this hormone supplement results in appetite is uncontrolled, making overeating far more likely."

A Chronic Disease?

Health authorities advise the injections for individuals with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.

Professionals say that, considering the likelihood of weight regain, the therapy is often life-long.

This view is supported by drug manufacturers, who say that the results "emphasize the persistent character of excess weight," comparing it to managing diseases like hypertension.

Patient Testimonies

Users who have discontinued the jabs describe a intense return of cravings.

"It felt as if a switch that goes on and I was suddenly starving," recalled an individual.

This challenge is compounded if users have not established lasting dietary or behavioural modifications during treatment.

Growing Interest

Figures indicate that a significant number of adults in the UK have tried these injections in the last 12 months, with desire being substantial.

• Use is greater among women compared to men.
• The middle-aged age group shows the highest level of interest.
• A large proportion access the medications through private healthcare rather than the NHS.

In conclusion, clinicians emphasize that while GLP-1 drugs are powerful tools for shedding pounds, they are not a magic solution and long-term success relies on ongoing behavioural changes.